These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21432822)

  • 1. Clinical and classic echocardiographic features of patients with, and without, left ventricle reverse remodeling following the introduction of cardiac resynchronization therapy.
    Wiliński J; Czarnecka D; Wojciechowska W; Kloch-Badełek M; Jastrzębski M; Bacior B; Sondej T; Kusak P; Przybyła A; Kawecka-Jaszcz K
    Cardiol J; 2011; 18(2):157-64. PubMed ID: 21432822
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical, echocardiographic, and neurohormonal response to cardiac resynchronization therapy: are they interchangeable?
    Hoogslag GE; Höke U; Thijssen J; Auger D; Marsan NA; Wolterbeek R; Holman ER; Schalij MJ; Bax JJ; Verwey HF; Delgado V
    Pacing Clin Electrophysiol; 2013 Nov; 36(11):1391-401. PubMed ID: 23826659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic importance of natriuretic peptides and atrial fibrillation in patients receiving cardiac resynchronization therapy.
    Smit MD; Maass AH; Hillege HL; Wiesfeld AC; Van Veldhuisen DJ; Van Gelder IC
    Eur J Heart Fail; 2011 May; 13(5):543-50. PubMed ID: 21330294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echocardiography-based qualification and response assessment to cardiac resynchronisation therapy in patients with chronic heart failure. The matrix metalloproteinase-9 substudy.
    Szulik M; Stabryła-Deska J; Boidol J; Lenarczyk R; Kalarus Z; Kukulski T
    Kardiol Pol; 2011; 69(10):1043-51. PubMed ID: 22006606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac resynchronization therapy in patients with chronic heart failure is associated with anti-inflammatory and anti-remodeling effects.
    Stanciu AE; Vatasescu RG; Stanciu MM; Iorgulescu C; Vasile AI; Dorobantu M
    Clin Biochem; 2013 Feb; 46(3):230-4. PubMed ID: 23159290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in NT-proBNP levels in patients with atrial fibrillation related to heart failure].
    Pokorná V; Jurkovicová O; Kaluzay J; Stecová A; Pont'uch P
    Vnitr Lek; 2010 Aug; 56(8):788-94. PubMed ID: 20845610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
    Roubicek T; Stros J; Kucera P; Nedbal P; Cerny J; Polasek R; Wichterle D
    PLoS One; 2019; 14(7):e0219966. PubMed ID: 31314790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response?
    Tawfik Ghanem M; Allam LE; Samir Ahmed R
    Indian Heart J; 2019; 71(3):229-234. PubMed ID: 31543195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cardiac resynchronization therapy on disease progression in patients with congestive heart failure.
    Bonanno C; Ometto R; Pasinato S; Finocchi G; La Vecchia L; Fontanelli A
    Ital Heart J; 2004 May; 5(5):364-70. PubMed ID: 15185900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association of plasma amino-terminal pro-A-, B- and C-type natriuretic peptide levels with NYHA grade and echocardiographic derived parameters of cardiac function in heart failure patients].
    Zhao XY; Yang YJ; Zhang J; Kang LM; Wei BQ; Gao XJ; Lü R; Zhang CL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2009 Jun; 37(6):486-90. PubMed ID: 19927626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The QRS narrowing index predicts reverse left ventricular remodeling following cardiac resynchronization therapy.
    Rickard J; Popovic Z; Verhaert D; Sraow D; Baranowski B; Martin DO; Lindsay BD; Varma N; Tchou P; Grimm RA; Wilkoff BL; Chung MK
    Pacing Clin Electrophysiol; 2011 May; 34(5):604-11. PubMed ID: 21276023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reverse electrical remodeling by cardiac resynchronization therapy: prevalence and clinical impact.
    Sebag FA; Martins RP; Defaye P; Hidden-Lucet F; Mabo P; Daubert JC; Leclercq C
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1219-27. PubMed ID: 22697464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of preoperative natriuretic peptides and echocardiographic parameters in predicting new-onset atrial fibrillation after coronary artery bypass grafting: a prospective comparative study.
    Gibson PH; Croal BL; Cuthbertson BH; Rae D; McNeilly JD; Gibson G; Jeffrey RR; Buchan KG; El-Shafei H; Hillis GS
    Am Heart J; 2009 Aug; 158(2):244-51. PubMed ID: 19619701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and echocardiographic characteristics of individuals aged 75/76 years old with screening-detected elevated NT-proBNP levels.
    Al-Khalili F; Kemp-Gudmundsdottir K; Svennberg E; Fredriksson T; Frykman V; Friberg L; Rosenqvist M; Engdahl J
    Open Heart; 2020; 7(1):e001200. PubMed ID: 32153793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pro-brain natriuretic peptide plasma levels, left ventricular dimensions and ejection fraction in acute dyspnoea.
    Shaikh K; Hanif B; Siddique AA; Shaikh MY; Khan MN
    J Coll Physicians Surg Pak; 2012 Dec; 22(12):751-5. PubMed ID: 23217478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnostic value of plasma concentration of pro-brain natriuretic peptide in congestive heart failure in pediatric patients with ventricular septal defects].
    Wu YR; Chen SB; Huang MR; Zhang YQ; Sun K; Chen S
    Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):161-4. PubMed ID: 15833183
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E/A ratio before cardiac resynchronization therapy predicts left ventricle reverse remodeling.
    Iori M; Bottoni N; Quartieri F; Manari A
    Minerva Cardioangiol; 2014 Aug; 62(4):305-9. PubMed ID: 25012099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-type natriuretic peptide level after sinus rhythm restoration in patients with persistent atrial fibrillation - clinical significance.
    Wozakowska-Kapłon B; Bartkowiak R; Grabowska U; Janiszewska G
    Kardiol Pol; 2010 Jul; 68(7):781-6. PubMed ID: 20648436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of Higher Frequency of Atrial Fibrillation in Patients with Cardiac Resynchronization Therapy.
    Grbović A; Pavlović S; Žugić V
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138281
    [No Abstract]   [Full Text] [Related]  

  • 20. Outcomes of cardiac resynchronization therapy in patients with atrial fibrillation accompanied by slow ventricular response.
    Hwang JK; Gwag HB; Park KM; On YK; Kim JS; Park SJ
    PLoS One; 2019; 14(1):e0210603. PubMed ID: 30633768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.